Gore Enform Intraperitoneal Biomaterial
Payments companies reported to CMS as associated with Gore Enform Intraperitoneal Biomaterial. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gore Enform Intraperitoneal Biomaterial, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gore Enform Intraperitoneal Biomaterial
These are the largest totals companies reported as associated with Gore Enform Intraperitoneal Biomaterial. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Omar Kudsi | Boston, MA | Surgery | $27,540.42 |
| Matthew Goldblatt | Milwaukee, WI | Surgery | $17,857.69 |
| John Linn | Glenview, IL | Surgery | $13,134.23 |
| Kamrun Jenabzadeh | Maple Grove, MN | Surgery | $12,986.88 |
| Leo Derosier | Tallahassee, FL | Surgery | $12,196.04 |
| Rana Higgins | Milwaukee, WI | Surgery | $10,796.70 |
| Flavio Malcher Martins De Oliveira | New York, NY | Surgery | $10,703.01 |
| Matthew Reynolds | Largo, FL | Surgery | $7,692.89 |
| Kaela Blake | Knoxville, TN | Surgery | $7,558.01 |
| Garth Jacobsen | San Diego, CA | Surgery | $7,383.00 |
Prescribed Gore Enform Intraperitoneal Biomaterial?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.